A round of financing has pulled in $5 million for Israeli startup Belkin Laser, a portfolio company of the RAD Biomed accelerator. The company intends to use the proceeds to conduct a large-scale clinical trial, with sites in Italy and the UK, and obtain CE mark approval for its laser device for treating glaucoma.
Israeli glaucoma treatment device maker gets $5M boost
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.